|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
8.170 -0.980 (-10.710%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 99,237 | 108.468% | 104,592 | 21,603 | 2,150 | 0 |
| Cost of Sales | (52,224) | 104.519% | (89,898) | (15,041) | (1,231) | -- |
| Gross Profit | 47,013 | 113.037% | 14,694 | 6,562 | 919 | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (26,140) | 1264.301% | -- | -- | -- | (3,250) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (9,843) | -41.578% | (29,803) | (39,655) | (27,377) | (1,675) | |
| Profit / (Loss) before Taxation | (279,950) | -48.608% | (1,023,530) | (1,146,284) | (584,507) | (209,290) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,789 | -51.250% | 11,356 | 6,478 | 1,586 | 416 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (277,161) | -48.580% | (1,012,174) | (1,139,806) | (582,921) | (208,874) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,183 | 107.948% | 9,716 | (15,287) | (16,638) | 41,099 |
| Depreciation & Amortisation | 61,439 | 0.094% | 111,759 | 100,706 | 35,373 | 4,457 |
| Directors' Emoluments | -- | -- | 45,868 | 46,486 | 36,843 | 5,718 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -29.000 | -48.214% | -106.000 | -119.000 | -63.000 | -27.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.592) | (0.937) | (0.588) | (0.136) |
| NBV per share ($) | 0.287 | -- | 0.542 | 1.479 | 2.497 | -- |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -277,161,000 |
| %Change | -48.580% |
| EPS / (LPS) | RMB -0.290 |
| NBV Per Share (¥) | RMB 0.287 |